Experts say the approach could also save millions of pounds by cutting projects or clinical trials that would otherwise fail.

The tool is said to predict “off-target” effects for seven drugs that could aid in cellular hypertrophy prevention.

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using ...

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

In this video interview, Yael Elish, founder, CEO, StuffThatWorks; and Julie Ross, president, CEO, Advanced Clinical, address ...

During a health-focused event in New York on Tuesday, Google announced the development of a new collection of “open” AI ...